Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 203.18

-1.4%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert L. Ray who wrote (25808)	9/28/1998 2:45:00 PM
From: Henry Niman	Read Replies (2) of 32384

Actually, the side effect news isn't news, but the trial suspension and looking for SERM partner is. LGND has SERM partnerships with most major players (LLY, AHP, PFE) but doesn't have a SERM deal with SBH. I believe that SBH's Idoxifene is farthest along in clinical trials (except for Tamoxifen and Evista, which are already on the market).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next